Penumbra (BSP:P2NB34) Inventories, Raw Materials & Components: R$583 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BSP:P2NB34 Penumbra Inc BSP:P2NB34
21 GF Score
Price R$55.13
GF Value R$57.24
Valuation Fairly Valued
! 1 Warning Sign
View Full Analysis

What is Penumbra Inventories, Raw Materials & Components?

Penumbra BSP:P2NB34 21 Inventories, Raw Materials & Components is R$583 Mil as of Jun. 2026. GuruFocus rates BSP:P2NB34 with a GF Score™ of 21/100 and a GF Value™ of R$57.24 (Fairly Valued). The stock has 1 warning sign investors should review.

Penumbra's inventories, raw materials & components for the quarter that ended in Jun. 2026 was R$583 Mil.

Penumbra's quarterly raw materials declined from Dec. 2025 (R$639 Mil) to Mar. 2026 (R$577 Mil) but then increased from Mar. 2026 (R$577 Mil) to Jun. 2026 (R$583 Mil).

Penumbra's annual raw materials increased from Dec. 2023 (R$586 Mil) to Dec. 2024 (R$817 Mil) but then declined from Dec. 2024 (R$817 Mil) to Dec. 2025 (R$639 Mil).

Penumbra Inventories, Raw Materials & Components Historical Data

* Premium members only.

The historical data trend for Penumbra's Inventories, Raw Materials & Components can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Penumbra Inventories, Raw Materials & Components Chart

Penumbra Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Inventories, Raw Materials & Components
Get a 7-Day Free Trial Premium Member Only Premium Member Only 386.65 476.21 585.58 817.33 638.87

Penumbra Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Inventories, Raw Materials & Components Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 679.87 623.70 638.87 576.51 582.55
BSP:P2NB34
21GF Score
Penumbra Inc BSP:P2NB34
Inventories, Raw Materials & Components is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Penumbra Inventories, Raw Materials & Components Calculation

Materials and components scheduled for use in making a product.

What does a Inventories, Raw Materials & Components of R$583 Mil mean?
Penumbra (BSP:P2NB34) has a Inventories, Raw Materials & Components of R$583 Mil as of Jun. 2026. Raw materials are the components a company uses for its main products. View historical data on Penumbra and its competitors.
Is Penumbra's Inventories, Raw Materials & Components too high?
Penumbra's current Inventories, Raw Materials & Components is R$583 Mil. Overall, Penumbra has a GF Score™ of 21/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Penumbra's Inventories, Raw Materials & Components compare to GMED and GKOS?
Penumbra's Inventories, Raw Materials & Components of R$583 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Inventories, Raw Materials & Components for a Medical Devices & Instruments company?
A good Inventories, Raw Materials & Components depends on the Medical Devices & Instruments industry context. However, Inventories, Raw Materials & Components should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Inventories, Raw Materials & Components mean?
A high Inventories, Raw Materials & Components can signal that a stock is expensive relative to its fundamentals. Raw materials are the components a company uses for its main products. View historical data on Penumbra and its competitors. Penumbra's current Inventories, Raw Materials & Components is R$583 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Penumbra stock overvalued right now?
Based on GuruFocus' analysis, Penumbra (BSP:P2NB34) is currently considered Fairly Valued. The stock's GF Value™ is R$57.24, compared to a current price of R$55.13 — trading 3.7% below its estimated fair value. The current Inventories, Raw Materials & Components is R$583 Mil. Penumbra's overall GF Score™ is 21/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Inventories, Raw Materials & Components calculated?
Inventories, Raw Materials & Components is calculated from a company's financial statements. For Penumbra (BSP:P2NB34), the current Inventories, Raw Materials & Components is R$583 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Penumbra (BSP:P2NB34) Overvalued in 2026?

Based on GuruFocus' analysis, Penumbra stock appears to be undervalued. The current stock price of R$55.13 is trading 3.7% below its estimated GF Value™ of R$57.24. GuruFocus considers Penumbra to be Fairly Valued.

Key valuation signals for BSP:P2NB34:

  • Inventories, Raw Materials & Components: R$583 Mil
  • GF Value™: R$57.24 vs. price of R$55.13 (3.7% below fair value)
  • GF Score™: 21/100 with 1 warning sign

No single metric tells the full story. See the BSP:P2NB34 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Penumbra Business Description

Other Exchanges PEN:USA
Address 1310 Harbor Bay Parkway, One Penumbra Place, Alameda, CA, USA, 94502
Penumbra Inc is a thrombectomy company focused on developing technologies for challenging medical conditions such as ischemic stroke, venous thromboembolism (including pulmonary embolism), and acute limb ischemia. Its portfolio includes Computer-Assisted Vacuum Thrombectomy (CAVT), which is designed to remove blood clots throughout the body. The company offers products such as the Artemis Neuro Evacuation Device (used for surgical removal of fluid and tissue from the ventricles and cerebrum), Indigo System, Penumbra System Reperfusion Catheter, LANTERN Delivery Microcatheter, Penumbra Smart Coil, and ACE Reperfusion Catheters, among others. The company generates maximum revenue from the sale of its products in the United States, followed by international markets.
21GF Score

Get the complete analysis for BSP:P2NB34

Inventories, Raw Materials & Components is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

R$55.13
Price
R$57.24
GF Value